The NKG2D receptor: immunobiology and clinical implications

被引：83

作者：

Burgess, Steven J. ^{[1
]}

Maasho, Kerima ^{[1
]}

Masilamani, Madhan ^{[1
]}

Narayanan, Sriram ^{[1
]}

Borrego, Francisco ^{[1
]}

Coligan, John E. ^{[1
]}

机构：

[1] NIAID, Cell Biol Sect, Immunogenet Lab, Natl Inst Hlth, Rockville, MD 20852 USA

来源：

IMMUNOLOGIC RESEARCH | 2008年 / 40卷 / 01期

关键词：

natural killer cells; T cells; activating receptor; DAP10;

D O I：

10.1007/s12026-007-0060-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

NK cells are critical components of our immune system functioning, in part, to recognize and then eradicate virally infected or tumorigenic cells without previous sensitization. One of the best-characterized activating receptors expressed on NK cells is the NKG2D receptor, which is capable of transmitting co-stimulatory signals by subsets of T cells. Viruses and tumors have evolved strategies to evade NKG2D-mediated immune recognition thus highlighting the importance of this receptor in immunity. This review will focus on the structure of NKG2D and its interaction with its diverse array of ligands, as well as highlighting current knowledge regarding NKG2D signal transduction and biological mechanisms that govern its cell surface expression. The impact that NKG2D has in disease pathologies is also assessed.

引用

页码：18 / 34

页数：17

共 113 条

[81] Structure and function of natural killer cell surface receptors [J].

Radaev, S ;

Sun, PD .

ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2003, 32 :93-114

[82] Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3 [J].

Radaev, S ;

Rostro, B ;

Brooks, AG ;

Colonna, M ;

Sun, PD .

IMMUNITY, 2001, 15 (06) :1039-1049

[83] Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma [J].

Raffaghello, L ;

Prigione, I ;

Airoldi, I ;

Camoriano, M ;

Levreri, I ;

Gambini, C ;

Pende, D ;

Steinle, A ;

Ferrone, S ;

Pistoia, V .

NEOPLASIA, 2004, 6 (05) :558-568

[84] Roles of the NKG2D immunoreceptor and its ligands [J].

Raulet, DH .

NATURE REVIEWS IMMUNOLOGY, 2003, 3 (10) :781-790

[85] NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors [J].

Regunathan, J ;

Chen, YH ;

Wang, DM ;

Malarkannan, S .

BLOOD, 2005, 105 (01) :233-240

[86] Cutting edge: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment [J].

Roberts, AI ;

Lee, L ;

Schwarz, E ;

Groh, V ;

Spies, T ;

Ebert, EC ;

Jabri, B .

JOURNAL OF IMMUNOLOGY, 2001, 167 (10) :5527-5530

[87] Three loci on mouse chromosome 6 influence onset and final incidence of type 1 diabetes in NOD.C3H congenic strains [J].

Rogner, UC ;

Boitard, C ;

Morin, J ;

Melanitou, E ;

Avner, P .

GENOMICS, 2001, 74 (02) :163-171

[88] Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells:: Up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein [J].

Rölle, A ;

Mousavi-Jazi, M ;

Eriksson, M ;

Odeberg, J ;

Söderberg-Nauclér, C ;

Cosman, D ;

Kärre, K ;

Cerboni, C .

JOURNAL OF IMMUNOLOGY, 2003, 171 (02) :902-908

[89] A structural basis for the association of DAP12 with mouse, but not human, NKG2D [J].

Rosen, DB ;

Araki, M ;

Hamerman, JA ;

Chen, T ;

Yamamura, T ;

Lanier, LL .

JOURNAL OF IMMUNOLOGY, 2004, 173 (04) :2470-2478

[90] Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia [J].

Salih, HR ;

Antropius, H ;

Gieseke, F ;

Lutz, SZ ;

Kanz, L ;

Rammensee, HG ;

Steinle, A .

BLOOD, 2003, 102 (04) :1389-1396

← 3 4 5 6 7 8 9 10 11 12 →